These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Filed by the Registrant
|
þ
|
Filed by a Party other than the Registrant
|
o
|
o
|
Preliminary Proxy
|
o
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
þ
|
Definitive Proxy Statement
|
o
|
Definitive Additional Materials
|
o
|
Soliciting Material Pursuant to Section 240.14a-12
|
þ
|
No fee required.
|
o
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
|
(1) |
Title of each class of securities to which transaction applies:
|
|
(2) | Aggregate number of securities to which transaction applies: |
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
(4) | Proposed maximum aggregate value of transaction: |
|
(5)
|
Total fee paid: |
o
|
Fee paid previously with preliminary materials.
|
(1)
|
To elect three (3) members to the Company’s Board of Directors;
|
(2)
|
To ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2013;
|
(3)
|
To approve the amendment and restatement of the EMCORE Corporation 2007 Directors’ Stock Award Plan;
|
(4)
|
To provide an advisory vote on executive compensation of the Company’s Named Executive Officers; and
|
(5)
|
To transact such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof.
|
|
By Order of the Board of Directors, | |
/s/ Alfredo Gomez, Esq. | ||
Alfredo Gomez | ||
Secretary |
Page | ||
1 | ||
1 | ||
1 | ||
2 | ||
3 | ||
3 | ||
Proposal I:
|
||
Election of Directors | 4 | |
5 | ||
7 | ||
8 | ||
14 | ||
15 | ||
22 | ||
28 | ||
28 | ||
28 | ||
29 | ||
29 | ||
30 | ||
31 | ||
Proposal II:
|
||
32 | ||
32 | ||
33 | ||
33 | ||
Proposal III:
|
||
34 | ||
35 | ||
Proposal IV:
|
||
36 | ||
36 | ||
|
||
37 | ||
Exhibit A: Amended and Restated 2007 Directors’ Stock Award Plan
|
(1)
|
To elect three (3) members to the Company’s Board of Directors;
|
(2)
|
To ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2013;
|
(3)
|
To approve the amendment and restatement of the EMCORE Corporation 2007 Directors’ Stock Award Plan;
|
(4)
|
To provide an advisory vote on executive compensation of the Company’s Named Executive Officers; and
|
(5)
|
To transact such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof.
|
(1)
|
By Internet
:
Go to
www.proxyvote.com
and follow the instructions;
|
(2)
|
By Telephone:
Call toll-free to
1-800-690-6903
and follow the instructions;
|
(3)
|
By Mail:
If you request a copy of the proxy materials by mail, complete, sign, date and return your proxy
card in the envelope supplied to you with written proxy materials; or
|
(4)
|
In Person
:
Attend the Annual Meeting and vote by ballot.
|
Name and Other Information
|
Age
|
Class and
Year in
Which Term Will
Expire
|
Principal Occupation
|
Served as
Director
Since
|
Hong Q. Hou, Ph.D.
|
48
|
Class B
2013
|
Chief Executive Officer, EMCORE Corporation
|
2006
|
Charles T. Scott
(1) (3) (5)
|
63
|
Class B
2013
|
Director
|
1998
|
Sherman McCorkle
(3) (4) (5)
|
69
|
Class B
2013
|
Chairman and Chief Executive Officer, Sandia Science and Technology Park Development Corporation
|
2009
|
Thomas J. Russell, Ph.D.
(2) (4) (5)
|
81
|
Class A
2014
|
Chairman Emeritus of the Board, EMCORE Corporation
|
1995
|
Reuben F. Richards, Jr.
|
57
|
Class A
2014
|
Chairman of the Board, EMCORE Corporation
|
1995
|
Robert L. Bogomolny
(1) (2) (5)
|
74
|
Class A
2014
|
President, University of Baltimore
|
2002
|
John Gillen
(1) (3) (5)
|
71
|
Class C
2015
|
Partner, Gillen and Johnson, P.A., Certified Public Accountants
|
2003
|
James A. Tegnelia, Ph.D.
(2) (4) (5)
|
70
|
Class C
2015
|
Lecturer, University of New Mexico and Georgetown University
|
2011
|
(1)
|
Member of Audit Committee.
|
(2)
|
Member of Nominating Committee.
|
(3)
|
Member of Compensation Committee.
|
(4)
|
Member of the Technology and Strategy Committee.
|
(5)
|
Determined by the Board of Directors to be an independent director according to the rules of The Nasdaq Stock Market (“Nasdaq”).
|
|
·
|
advise the Chairman of the Board as to an appropriate schedule of Board meetings;
|
|
·
|
provide the Chairman of the Board with input as to the preparation of agendas for Board and Committee meetings;
|
|
·
|
advise the Chairman of the Board as to the quality, quantity, and timeliness of the flow of information from the Company's management that is necessary for the independent directors to effectively and responsibly perform their duties;
|
|
·
|
recommend to the Chairman of the Board the retention of consultants who report directly to the Board;
|
|
·
|
coordinate the scheduling of, develop the agenda for, and preside over executive sessions of the independent directors;
|
|
·
|
act as principal liaison between the independent directors and the Chairman of the Board on sensitive issues; and
|
|
·
|
evaluate, along with the members of the Compensation Committee (consistent with the Compensation Committee Charter) and the full Board, the performance of the CEO and meet with the CEO to discuss the Board's evaluation.”
|
|
·
|
For each of the last three years, the accounting firm of Gillen and Johnson, P.A. has prepared the individual U.S. tax returns for Dr. Russell for a fee of approximately $2,500 per year, which was paid directly by Dr. Russell to Gillen and Johnson, P.A.
|
|
·
|
For each of the last three years, Mr. Gillen has acted as sole trustee of the Morning Star Trust, which was established by Dr. Russell for the benefit of Dr. Russell’s daughter and owned approximately 850,000 shares of the Company’s Common Stock as of December 31, 2012. Mr. Gillen was not paid any fees in connection with his service as trustee of the Morning Star Trust.
|
|
·
|
discussing the Company’s strategic plan, including any proposed merger or acquisition;
|
|
·
|
considering technological innovations relevant to the business of the Company;
|
|
·
|
considering and discussing strategic initiatives and new technologies that the Committee believes could contribute to the achievement of the Company’s strategic plan; and
|
|
·
|
upon request of the Board from time to time, providing advice and assistance with regard to evaluating potential strategic initiatives that fall within the scope of the Committee’s purposes.
|
Name (1)
|
Fees Earned or
Paid in Cash
($)(2)
|
Stock
Awards
($)(3)
|
Total
($)
|
|||||||||
Thomas J. Russell, Ph.D.
|
26,300 | 38,000 | 64,300 | |||||||||
Charles T. Scott
|
30,150 | 44,500 | 74,650 | |||||||||
John Gillen
|
29,550 | 48,500 | 78,050 | |||||||||
Robert L. Bogomolny
|
24,300 | 36,500 | 60,800 | |||||||||
Sherman McCorkle
|
26,100 | 42,500 | 68,600 | |||||||||
James A. Tegnelia, Ph.D.
|
22,350 | 25,500 | 47,850 |
(1)
|
Reuben F. Richards, Jr., the Company’s Executive Chairman and Chairman of the Board, and Hong Q. Hou, Ph.D., the Company’s Chief Executive Officer, are not included in this table because they were employees of the Company during fiscal year 2012 and received no compensation for their services as directors. Their compensation is disclosed in the Summary Compensation Table below. Mr. Richards stepped down as Executive Chairman effective as of September 30, 2012, and is currently receiving certain payments and benefits under a separation agreement and general release, dated August 6, 2012 (the “Separation Agreement”) entered into between Mr. Richards and the Company. He will not receive compensation as a non-employee director while he is receiving such payments and benefits under the Separation Agreement.
|
(2)
|
The amounts in this column reflect the dollar amounts earned or paid in cash for services rendered in fiscal year 2012.
|
(3)
|
The amounts in this column reflect the dollar amounts granted for services rendered in calendar year 2011 under the Company’s 2007 Directors’ Stock Award Plan, payment of which is made in Common Stock of the Company.
|
|
·
|
Dr. Hou – 80% of base salary
|
|
·
|
Mr. Larocca – 50% of base salary
|
|
·
|
Mr. Weinswig – 50% of base salary
|
|
·
|
Mrs. Van Berkel – 35% of base salary
|
|
·
|
On December 6, 2011, the Compensation Committee approved the following grants of restricted stock units for the Named Executive Officers to compensate them for lost wages as a result of the base salary reductions discussed above and to provide them with long-term incentives and to promote retention of these executives during this difficult economic time.
|
Name
|
Number of
Restricted Stock
Units
|
|
Reuben F. Richards, Jr.
|
23,750
|
|
Hong Q. Hou, Ph.D.
|
23,750
|
|
Mark Weinswig
|
12,000
|
|
Christopher Larocca
|
12,000
|
|
Monica Van Berkel
|
9,025
|
|
·
|
On March 8, 2012, the Compensation Committee approved the following grants of restricted stock units for Mr. Richards and Dr. Hou to compensate them for the restricted stock units that were previously granted in August 2011, but canceled in December 2011 for no value to comply with the award limits included in the 2010 Plan:
|
Name
|
Number of
Restricted Stock
Units
|
|
Reuben F. Richards, Jr.
|
10,000
|
|
Hong Q. Hou, Ph.D.
|
10,000
|
|
·
|
In June 2012, the Compensation Committee approved the following fully vested grants of restricted stock units for the following Named Executive Officers in recognition of their achievements during the prior 18-month period, including, the implementation of new administrative IT systems, improving internal efficiencies and successfully negotiating & closing the sale of its Enterprise product lines to Sumitomo Electric Device Innovations USA.
|
Name
|
Number of
Restricted Stock
Units
|
|
Mark Weinswig.
|
12,500
|
|
Monica Van Berkel
|
7,500
|
Name
|
Number of
Restricted Stock
Units
|
|
Hong Q. Hou, Ph.D.
|
40,000
|
|
Mark Weinswig
|
20,000
|
|
Christopher Larocca
|
20,000
|
|
Monica Van Berkel
|
15,000
|
Name and Principal
Position
|
Year
|
Salary
($)
|
Bonus
($)
(3)
|
Stock Awards
($)
(4)
|
Option Awards
($)
(4)
|
All Other
Compensation
($)
|
Total
($)
|
||||||||||||||||||||||
Reuben F. Richards, Jr.
Executive Chairman and
Chairman of the Board
(1)
|
2012
2011
2010
|
419,260
450,445
434,129
|
0
0
85,000
|
145,350
290,500
0
|
0
0
0
|
364
364
384
|
(5)
(5)
(5)
|
564,974
741,309
519,513
|
|||||||||||||||||||||
Hong Q. Hou, Ph.D.
Chief Executive Officer
|
2012
2011
2010
|
419,260
450,445
425,167
|
0
0
85,000
|
145,350
290,500
0
|
0
0
0
|
9,213
7,832
7,450
|
(6)
(7)
(8)
|
573,823
748,777
517,617
|
|||||||||||||||||||||
Mark Weinswig
Chief Financial Officer
(2)
|
2012
2011
|
248,000
260,000
|
0
0
|
92,580
77,500
|
0
209,430
|
7,567
11,964
|
(9)
(10)
|
348,147
558,894
|
|||||||||||||||||||||
Christopher Larocca
Chief Operating Officer
|
2012
2011
2010
|
248,000
260,000
250,603
|
0
0
26,000
|
46,080
176,900
0
|
0
0
0
|
7,417
7,498
8,452
|
(11)
(12)
(13)
|
301,497 444,398 285,055 | |||||||||||||||||||||
Monica Van Berkel
Chief Administration Officer
|
2012
2011
2010
|
220,404
222,500
214,327
|
0
0
15,575
|
62,556
154,950
0
|
0
0
0
|
7,052
7,506
7,330
|
(14)
(15)
(16)
|
290,012 384,956 237,232 |
(1)
|
Mr. Richards also served as Interim Chief Financial Officer from August 14, 2010 to October 8, 2010. He stepped down as Executive Chairman effective September 30, 2012, but will continue to serve as Chairman of the Board.
|
(2)
|
Mr. Weinswig was retained as Chief Financial Officer on October 8, 2010.
|
(3)
|
The amounts in this column reflect the cash bonuses earned in each fiscal year in which they were reported, as approved by the Compensation Committee, and were paid in the following fiscal year.
|
(4)
|
The amounts in this column represent the grant date fair value, in accordance with FASB Accounting Standards Codification No. 718 - “Compensation – Stock Compensation” (without regard to estimated forfeitures related to a service based condition). Assumptions used in the calculation of these amounts are set forth in footnote 4 to the Company’s audited financial statements for the fiscal year ended September 30, 2010, included in the Company’s Annual Report on Form 10-K filed with the SEC on January 10, 2011, footnote 15 to the Company’s audited financial statements for the fiscal year ended September 30, 2011, included in the Company’s Annual Report on Form 10-K filed with the SEC on December 29, 2011, and footnote 16 to the Company’s audited financial statements for the fiscal year ended September 30, 2012, included in the Company’s Annual Report on Form 10-K filed with the SEC on December 13, 2012. These amounts reflect the Company’s accounting expense for these awards and do not necessarily correspond to the actual value that will be recognized by the Named Executive Officer.
|
(5)
|
Consists of life insurance premiums.
|
(6)
|
Consists of life insurance premiums of $364 and EMCORE’s matching contributions under its 401(k) plan of $8,849 which are made in EMCORE Common Stock.
|
(7)
|
Consists of life insurance premiums of $364 and EMCORE’s matching contributions under its 401(k) plan of $7,468, which are made in EMCORE Common Stock.
|
(8)
|
Consists of life insurance premiums of $384 and EMCORE’s matching contributions under its 401(k) plan of $7,066, which are made in EMCORE Common Stock.
|
(9)
|
Consists of life insurance premiums of $364 and EMCORE’s matching contributions under its 401(k) plan of $7,203, which are made in EMCORE Common Stock.
|
(10)
|
Consists of life insurance premiums of $364, EMCORE’s matching contributions under its 401(k) plan of $6,600, which are made in EMCORE Common Stock and $5,000 in relocation expenses.
|
(11)
|
Consists of life insurance premiums of $364 and EMCORE’s matching contributions under its 401(k) plan of $7,053, which are made in EMCORE Common Stock.
|
(12)
|
Consists of life insurance premiums of $364 and EMCORE’s matching contributions under its 401(k) plan of $7,134, which are made in EMCORE Common Stock.
|
(13)
|
Consists of life insurance premiums of $384 and EMCORE’s matching contributions under its 401(k) plan of $8,068, which are made in EMCORE Common Stock.
|
(14)
|
Consists of life insurance premiums of $364 and EMCORE’s matching contributions under its 401(k) plan of $6,688, which are made in EMCORE Common Stock.
|
(15)
|
Consists of life insurance premiums of $364 and EMCORE’s matching contributions under its 401(k) plan of $7,142, which are made in EMCORE Common Stock.
|
(16)
|
Consists of life insurance premiums of $384 and EMCORE’s matching contributions under its 401(k) plan of $6,946, which are made in EMCORE Common Stock.
|
Name
|
Grant Date
|
Approval
Date
|
All Other Stock Awards:
Number of Shares of
Stocks or Units (#)
|
Grant Date Fair Value of
Stock and Option
Awards
($) (1)
|
||||||||
|
|
|
||||||||||
Reuben F. Richards, Jr.
|
1/30/12
3/8/12
|
(2)
|
12/6/11
|
23,750
10,000
|
105,450
39,900
|
|||||||
Hong Q. Hou, Ph.D.
|
1/30/12
3/8/12
|
(2)
|
12/6/11
|
23,750
10,000
|
105,450
39,900
|
|||||||
Mark Weinswig
|
12/6/12
6/25/12
|
12,500
|
46,080
46,500
|
|||||||||
Christopher Larocca
|
12/6/12
|
12,000 | 46,080 | |||||||||
Monica Van Berkel
|
12/6/12
6/25/12
|
9,025
7,500
|
34,656
27,900
|
(1)
|
The amounts in this column represent the grant date fair value, in accordance with FASB Accounting Standards Codification No. 718 - “Compensation – Stock Compensation” (without regard to estimated forfeitures related to a service based condition). Assumptions used in the calculation of these amounts are set forth in footnote 16 to the Company’s audited financial statements for the fiscal year ended September 30, 2012, included in the Company’s Annual Report on Form 10-K filed with the SEC on December 13, 2012. These amounts reflect the Company’s accounting expense for these awards and do not necessarily correspond to the actual value that will be recognized by the Named Executive Officer.
|
(2)
|
The Compensation Committee approved these grants of restricted stock units on December 6, 2011. Since Mr. Richards and Dr. Hou had met their limits for restricted stock units under the 2010 Equity Incentive Plan as of December 6, 2011, their grants were approved for issuance effective January 30, 2012, the first business day after the twelve-month limits expired and they were eligible to receive another grant of restricted stock units under the terms of the 2010 Equity Incentive Plan.
|
Option Awards
|
Stock Awards
|
||||||||||||||||||||
Name |
Number of Securities Underlying
Unexercised Options
(#)
Exercisable
|
Number of Securities Underlying Unexercised Options
(#)
Unexercisable
|
Option
Exercise
Price
($)
|
Option
Expiration
Date
|
Number of
Shares or
Units of
Stock That
Have Not
Vested
(#)
|
Market Value
of Shares or Units of Stock That Have
Not Vested
($)(1)
|
|||||||||||||||
Reuben F. Richards, Jr.
(2)
|
18,125
56,250
125,000
25,000
50,000
|
-
-
-
-
-
|
10.52
13.68
23.04
33.52
5.00
|
5/18/14
5/18/15
9/30/15
9/30/15
9/30/15
|
- | - | |||||||||||||||
Hong Q. Hou, Ph.D.
|
8,750
1,718
13,750
61,250
63,751
37,500
48,751
37,499
|
(3)
|
-
-
-
-
12,501
|
(4) |
11.56
12.00
29.16
23.04
35.12
26.68
33.52
5.00
|
5/18/14
2/28/15
8/28/16
12/14/16
9/25/17
4/3/18
5/19/18
7/27/19
|
61,145 | (8) | 345,469 | ||||||||||||
Mark Weinswig
|
15,000 | 60,000 | (5) | 3.80 |
10/11/20
|
17,333 | (9) | 97,931 | |||||||||||||
Christopher Larocca
|
10,000
3,250
332
3,000
500
1,750
7,500
7,501
18,751
5,624
37,500
15,000
|
-
-
-
-
-
-
-
-
1,876
12,500
5,000
|
(6)
(7)
(4)
|
11.72
12.00
29.28
31.80
39.00
29.16
19.90
35.12
33.52
2.76
5.24
5.00
|
5/19/14
2/28/15
12/29/15
3/10/16
4/5/16
8/28/16
3/29/17
9/25/17
5/19/18
2/27/19
5/29/19
7/27/19
|
29,000 | (10) | 163,850 |
Option Awards
|
Stock Awards
|
||||||||||||||||||||||
Name
|
Number of
Securities
Underlying
Unexercised
Options
(#)
Exercisable
|
Number of
Securities
Underlying
Unexercised
Options
(#)
Unexercisable
|
Option
Exercise
Price
($)
|
Option
Expiration
Date
|
Number of
Shares or
Units of
Stock That
Have Not
Vested
(#)
|
Market Value
of Shares or
Units of Stock
That Have
Not Vested
($)(1)
|
|||||||||||||||||
Monica Van Berkel
|
6,812
3,750
179
11,250
5,000
2,500
17,501
14,062
15,000
|
-
-
-
-
-
-
4,689
5,000
|
(7)
(4)
|
12.32
12.00
29.28
29.16
19.90
35.12
33.52
5.24
5.00
|
5/24/14
2/28/15
12/29/15
8/28/16
3/29/17
9/25/17
5/19/18
5/29/19
7/27/19
|
24,268 |
(11)
|
137,114 |
(1)
|
The market value is determined by multiplying the number of shares by $5.65, the closing trading price of EMCORE common stock on the Nasdaq Global Market on September 28, 2012, the last trading day of the fiscal year.
|
(2)
|
Effective September 30, 2012, Mr. Richards stepped down as Executive Chairman of EMCORE, and entered into the Separation Agreement, which provided for the immediate vesting of all outstanding equity awards Mr. Richards had previously been granted under the Company’s various equity awards plans.
|
(3)
|
In December 2008, pursuant to the terms of a tender offer relating to outstanding stock options, the exercise price was increased from $10.52 to $11.56 (on a post-reverse stock split basis), which represents the fair market value as of the actual measurement date for this option grant.
|
(4)
|
The unvested portions of these awards are scheduled to vest on July 27, 2013.
|
(5)
|
The unvested portions of these awards are scheduled to vest on October 11, 2012, 2013, 2014 and 2015.
|
(6)
|
The unvested portions of these awards are scheduled to vest on February 27, 2013.
|
(7)
|
The unvested portions of these awards are scheduled to vest on May 29, 2013.
|
(8)
|
Consists of the following restricted shares and units: (a) 25,000 restricted shares of EMCORE Common Stock granted on January 28, 2011, that are scheduled to vest in two equal installments on January 28, 2013 and 2014; (b) 8,333 restricted stock units of EMCORE common stock that were granted on August 22, 2011 and are scheduled to vest in two equal installments on August 22, 2013, and 2014; (c) 17,812 restricted stock units that were granted on January 30, 2012 and are scheduled to vest in three equal installments on January 30, 2013, 2014 and 2015, and (d) 10,000 restricted stock units that were granted on March 8, 2012 and are scheduled to vest in three equal installments on March 8, 2013, 2014 and 2015.
|
(9)
|
Consists of the following restricted stock units: (a) 8,333 restricted stock units that were granted on August 22, 2011 and are scheduled to vest in two equal installments on August 22, 2013, and 2014; and (b) 9,000 restricted stock units that were granted on December 6, 2011 and are scheduled to vest in three equal installments on December 6, 2012, 2013, and 2014.
|
(10)
|
Consists of the following restricted shares and units: (a) 11,667 restricted shares of EMCORE Common Stock granted on January 28, 2011, that are scheduled to vest in two equal installments on January 28, 2013 and 2014; (b) 8,333 restricted stock units that were granted on August 22, 2011 and are scheduled to vest in two equal installments on August 22, 2013, and 2014; and (c) 9,000 restricted stock units that were granted on December 6, 2011 and are scheduled to vest in three equal installments on December 6, 2012, 2013, and 2014.
|
(11)
|
Consists of the following restricted shares and units: (a) 10,000 restricted shares of EMCORE Common Stock granted on January 28, 2011, that are scheduled to vest in two equal installments on January 28, 2013 and 2014; (b) 7,500 restricted stock units that were granted on August 22, 2011 and are scheduled to vest in two equal installments on August 22, 2013, and 2014; and (c) 6,768 restricted stock units that were granted on December 6, 2011 and are scheduled to vest in three equal installments on December 6, 2012, 2013, and 2014.
|
Option Awards
|
Stock Awards
|
||||||
Name
|
Number of shares
acquired on
exercise
(#)
|
|
Value realized
on exercise
(#)
|
|
Number of shares
acquired on vesting
(#)
|
Value realized on
vesting
($)
|
|
Reuben F. Richards, Jr.
(1)
|
--
|
--
|
83,750
|
459,773
|
|||
Hong Q. Hou, Ph.D.
|
--
|
--
|
22,605
|
114,304
|
|||
Mark Weinswig
|
--
|
--
|
19,667
|
82,997
|
|||
Christopher Larocca
|
--
|
--
|
13,000
|
65,895
|
|||
Monica Van Berkel
|
--
|
--
|
18,507
|
83,712
|
(1)
|
Effective September 30, 2012, Mr. Richards stepped down as Executive Chairman of EMCORE, and entered into the Separation Agreement, which provided for the immediate vesting of all outstanding equity awards Mr. Richards had previously been granted under the Company’s various equity awards plans.
|
Name
|
Severance
|
COBRA
(Company Part Only)
|
Outplacement Services
|
|||||||||
Hong Q. Hou, Ph.D.
|
$ | 710,317 | $ | 21,769 | $ | 15,000 | ||||||
Mark Weinswig
|
$ | 280,000 | $ | 16,931 | $ | 15,000 | ||||||
Christopher Larocca
|
$ | 380,000 | $ | 21,769 | $ | 15,000 | ||||||
Monica Van Berkel
|
$ | 299,519 | $ | 21,769 | $ | 15,000 |
Name
|
Value of stock options, restricted
stock awards and restricted stock
units on Acceleration
($)
|
|
Hong Q. Hou, Ph.D.
|
353,595
|
|
Mark Weinswig.
|
208,931
|
|
Christopher Larocca
|
177,647
|
|
Monica Van Berkel
|
139,850
|
|
(i)
|
the Company will continue to pay Mr. Richards his current base salary of $450,445 per annum for a period of 88 weeks, commencing on October 1, 2012;
|
|
(ii)
|
all of the unvested restricted stock and restricted stock units held by Mr. Richards vested as of September 30, 2012, which had a value of $345,469 based on a stock price of $5.65, which was the closing price of the Company’s Common Stock on the Nasdaq Global Market on September 28, 2012;
|
|
(iii)
|
all of Mr. Richards’ outstanding unvested stock options vested as of September 30, 2012, and must be exercised within three (3) years of September 30, 2012 (but no later than the expiration of the term of the applicable stock option), and such unvested stock options had a value of $8,125, which reflects the difference between the exercise price of these stock options and a stock price of $5.65, which was the closing price of the Company’s Common Stock on the Nasdaq Global Market on September 28, 2012;
|
|
(iv)
|
Mr. Richards, his spouse and his eligible dependents shall continue to participate in the Company’s health plans on the same terms as they currently participate in such plans, for so long as Mr. Richards is serving as the Chairman of the Board. When Mr. Richards is no longer serving as Chairman of the Board, Mr. Richards will be eligible to exercise his rights to COBRA, and in the event Mr. Richards exercises such rights, then the Company will pay the portion of Mr. Richards’ COBRA premiums for eighteen (18) months following the date he no longer serves as Chairman of the Board that the Company would have otherwise paid if Mr. Richards were still an active employee during such period. The estimated value of such COBRA premium payments is $21,769; and
|
|
(v)
|
the Company will provide Mr. Richards with standard outplacement services for up to 12 months after September 30, 2012, at the Company’s expense up to a maximum amount of $15,000.
|
|
COMPENSATION COMMITTEE
John Gillen, Chairman
Sherman McCorkle
Charles T. Scott
|
·
|
A Balanced Mix of Compensation Components
.
The program design provides a balanced mix of cash and equity, annual and longer-term incentives, and performance metrics.
|
·
|
Multiple Performance Factors
. Our incentive compensation plans use both company-wide metrics and individual performance, which encourage focus on the achievement of several objectives for the overall benefit of the Company. The annual cash incentive is dependent upon multiple performance metrics including revenue and EBIT, as well as individual goals related to specific strategic or operational objectives. The long-term incentives are equity-based and granted annually with a three, four or five year vesting schedule, to create incentives for the executives to focus on the long-term performance of the Company.
|
·
|
Focus on Long-term Incentives
.
Long-term incentive compensation is an integral part of compensation that discourages short-term risk taking.
|
·
|
Managed Expectations
.
Goals are appropriately set to avoid targets that, if not achieved, result in a large percentage loss of compensation.
|
·
|
Capped Incentive Awards
.
Maximum funding level of the executive bonus program is capped at 120 percent of target.
|
Name
|
Shares Beneficially
Owned
(1)
|
Percent of
Common Stock
|
|||||||
Thomas J. Russell, Ph.D.
|
1,705,874 | (2) | 6.46 | % | |||||
Reuben F. Richards, Jr.
|
496,011 | (3) | 1.86 | % | |||||
Robert L. Bogomolny
|
65,321 | * | |||||||
Charles T. Scott
|
58,928 | (4) | * | ||||||
John Gillen
|
57,597 | * | |||||||
Sherman McCorkle
|
27,828 | (5) | * | ||||||
James A. Tegnelia, Ph.D.
|
4,980 | * | |||||||
Hong Q. Hou, Ph.D.
|
366,286 | (6) | 1.37 | % | |||||
Mark Weinswig
|
59,429 | (7) | * | ||||||
Christopher Larocca
|
137,944 | (8) | * | ||||||
Monica Van Berkel
|
105,751 | (9) | * | ||||||
All directors and executive officers as a group
(11 persons)
|
3,085,949 | (10) | 11.35 | % | |||||
Kopp Investment Advisors, LLC
|
2,073,975 | (11) | 7.85 | % |
*
|
Less than 1.0%
|
(1)
|
As of January 10, 2013, 26,418,973 shares of Common Stock were outstanding.
|
(2)
|
Includes 856,016 shares of Common Stock held by The Morning Star Trust for the benefit of Dr. Russell’s daughter.
|
(3)
|
Includes options to purchase 274,375 shares of Common Stock exercisable within 60 days of January 10, 2013, 43,750 shares of Common Stock held by spouse, 2,500 shares of Common Stock held by spouse in a pension fund and 2,500 shares of Common Stock held in trust for the benefit of Mr. Richards’ daughter.
|
(4)
|
Includes 34,125 shares of Common Stock owned by Kircal, Ltd.
|
(5)
|
Includes 10,250 shares of Common Stock held in Mr. McCorkle’s 401(k) Plan as of December 31, 2012.
|
(6)
|
Includes 25,000 restricted shares of Common Stock that remain subject to vesting, 9,272 restricted stock units exercisable within 60 days of January 10, 2013, options to purchase 272,969 shares of Common Stock exercisable within 60 days of January 10, 2013, and 7,730 shares of Common Stock held in the Company’s 401(k) Plan as of December 31, 2012.
|
(7)
|
Includes options to purchase 30,000 shares of Common Stock exercisable within 60 days of January 10, 2013 and 3,020 shares of Common Stock held in the Company’s 401(k) Plan as of December 31, 2012.
|
(8)
|
Includes 11,667 restricted shares of Common Stock that remain subject to vesting, options to purchase 112,584 shares of Common Stock exercisable within 60 days of January 10, 2013 and 7,228 shares of Common Stock held in the Company’s 401(k) Plan as of December 31, 2012.
|
(9)
|
Includes 10,000 restricted shares of Common Stock that remain subject to vesting, options to purchase 76,055 shares of Common Stock exercisable within 60 days of January 10, 2013 and 6,745 shares of Common Stock held in the Company’s 401(k) Plan as of December 31, 2012.
|
(10)
|
Includes 46,667 restricted shares of Common Stock that remain subject to vesting, 9,272 restricted stock units exercisable within 60 days of January 10, 2013, and options to purchase 765,983 shares of Common Stock exercisable within 60 days of January 10, 2013.
|
(11)
|
This information is based solely on information contained in a Schedule 13D filed with the SEC on October 8, 2010, by Kopp Investment Advisors, LLC (“KIA”), a wholly-owned subsidiary of Kopp Holding Company, LLC (“KHC”), which is controlled by Mr. LeRoy C. Kopp (“Kopp”) (collectively, the “Kopp Parties”). KIA reports beneficially owning a total of 8,295,900 shares of Common Stock including having sole voting power over 0 shares of Common Stock and shared dispositive power over 2,940,900 shares of Common Stock. KHC reports beneficially owning 8,295,900 shares of Common Stock including having sole voting power over 0 shares of Common Stock and shared dispositive power over 2,940,900 shares of Common Stock. Kopp reports beneficially owning a total of 8,295,900 shares of Common Stock including having sole voting power over 5,355,000 shares of Common Stock and shared dispositive power over 2,940,900 shares of Common Stock. The address of the Kopp Parties is 8400 Normandale Lake Blvd., Suite 1450, Bloomington, Minnesota, 55437.
|
Plan Category
|
Number of securities
to be issued upon
exercise of outstanding
options, warrants and
rights
|
Weighted average
exercise price
of outstanding options,
warrants and rights
|
Number of securities
remaining available for future
issuance under equity
compensation plans
(excluding securities reflected in column (a))
|
|||||||||||
|
(a)
|
(b)
|
(c)
|
|||||||||||
Equity compensation plans approved by security holders
|
2,032,215 | (1) | $ | 17.76 | 1,817,994 | (2) | ||||||||
Equity compensation plans not approved by security holders
|
-- | -- | -- |
(1)
|
Consists of outstanding stock options under the EMCORE Corporation 2000 Stock Option Plan, the EMCORE Corporation 2010 Equity Incentive Plan and the EMCORE Corporation 2012 Equity Incentive Plan as of September 30, 2012.
|
(2)
|
Consists of 37,927 shares that remained available for grant under the EMCORE Corporation 2010 Equity Incentive Plan, as amended, 1,000,000 shares that remained available for grant under the EMCORE Corporation 2012 Equity Incentive Plan, and 780,067 shares that remained available for grant under the EMCORE Corporation 2000 Employee Stock Purchase Plan, as of September 30, 2012. In addition, 94,811 shares remained available for grant under the Company’s Officer and Director Share Purchase Plan. The Company’s 2000 Stock Option Plan expired on February 12, 2010, and no additional shares were available for grant under that plan after the termination date. In addition to the shares listed above, the Company compensates its non-employee directors for their services pursuant to the 2007 Directors’ Stock Award Plan. In accordance with the 2007 Directors’ Stock Award Plan, payments of fees are made in Common Stock of the Company. Non-employee directors earn a fee in the amount of $3,500 per Board meeting attended and $500 per committee meeting attended ($1,000 for the chairman of a committee). When Board members are invited to attend meetings of Board committees of which they are not members, these non-committee Board members earn a committee meeting fee of $500.
|
Fiscal 2012
|
Fiscal 2011
|
|||||||
|
|
|||||||
Audit fees
(1)
|
$ | 1,008,254 | $ | 1,136,460 | ||||
Audit-related fees
|
-- | -- | ||||||
Tax fees
|
-- | -- | ||||||
All other fees
|
-- | -- | ||||||
Total
|
$ | 1,008,254 | $ | 1,136,460 |
(1)
|
Represents fees for professional services rendered in connection with the integrated audit of our annual financial statements, reviews of our quarterly financial statements, other SEC filings, including registration statements, correspondence with the SEC, and advice provided on accounting matters that arose in connection with audit services.
|
|
AUDIT COMMITTEE
Charles T. Scott, Chairman
Robert L. Bogomolny
John Gillen
|
|
By Order of the Board of Directors,
/s/ Alfredo Gomez
Alfredo Gomez, Esq.
Secretary
|
1.
|
Purposes of the Plan
. The purposes of the 2007 Directors' Stock Award Plan are (a) to attract and retain highly qualified individuals to serve as Directors of the Company, (b) to increase Non-Employee Director’s stock ownership in the Company and (c) to relate Non-Employee Director’s compensation more closely to the Company's performance and its shareholders' interest.
|
2.
|
Certain Definitions
. As used herein, the following definitions shall apply:
|
|
(a)
|
“Account” means a bookkeeping account established under the Plan for a Non-Employee Director to which shares of Common Stock have been or are to be credited in the form of phantom stock (i.e., a contractual right to receive a stated number of shares of Common Stock at such time as provided under the Plan). Each Account represents an unfunded and unsecured obligation of the Company.
|
|
(b)
|
“Adjustment Event” means any dividend payable in capital stock, stock split, share combination, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, split-up, spin-off, combination, exchange of shares or other similar event affecting the Common Stock.
|
|
(c)
|
“Affiliate” means, with respect to any person, any other person that, directly or indirectly, is in control of, is controlled by, or is under common control with, the first person.
|
|
(d)
|
“Annual Stock Award Amount” has the meaning provided in Section 5.
|
|
(e)
|
“Beneficiary” has the meaning provided in Section 7.5.
|
|
(f)
|
“Board” means the Board of Directors of the Company.
|
|
(g)
|
“Change in Control” shall have the same meaning ascribed to such term under the EMCORE Corporation 2010 Equity Incentive Plan, as amended from time to time, provided that no Change in Control shall be deemed to occur for purposes of the Plan if a “change in control event” as defined under Code Section 409A does not also occur.
|
|
(h)
|
“Change in Control Price” shall have the same meaning ascribed to such term under the EMCORE Corporation 2010 Equity Incentive Plan.
|
|
(i)
|
“Code” means the Internal Revenue Code of 1986, as amended, and the regulations and other guidance promulgated thereunder.
|
|
(j)
|
“Common Stock” means the no par value common stock of the Company and any other securities into which the Common Stock is changed or for which the Common Stock is exchanged.
|
|
(k)
|
“Company” means EMCORE Corporation, a New Jersey corporation, and any successor thereto.
|
|
(l)
|
“Credit Date” means: (1) for Plan Years prior to the 2013 Plan Year, February 1
st
of the immediate following Plan Year, and (2) for Plan Years commencing with and following the 2013 Plan Year, January 2
nd
of the immediate following Plan Year; provided, however, in either case, that if such date is not a business day, the next succeeding business day shall be the Credit Date.
|
(m)
|
“Director” means any individual who is a member of the Board.
|
|
(n)
|
“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
|
|
(o)
|
“Fair Market Value” means of a share of Common Stock as of a given date shall be: (i) if the Common Stock is listed or admitted to trading on an established stock exchange (including, for this purpose, The Nasdaq Global Market that comprises part of The Nasdaq Stock Market), the closing sale price for a share of Common Stock on the composite tape or in Nasdaq Global Market trading as reported in
The Wall Street Journal
(or, if not so reported, such other nationally recognized reporting source as the Board shall select) on such date, or, if no such price is reported on such date, the most recent day for which such price is available shall be used; (ii) if the Common Stock is not then listed or admitted to trading on such a stock exchange, the closing sale price for a share of Common Stock on such date as reported by The Nasdaq Capital Market or, if not so reported, by the OTC Bulletin Board (or any successor or similar quotation system regularly reporting the market value of the Common Stock in the over-the-counter market), or, if no such price is reported for such date, the most recent day for which such price is available shall be used; or (iii) in the event neither of the valuation methods provided for in clauses (i) and (ii) above is practicable, the fair market value of a share of Common Stock determined by such other reasonable valuation method as the Board shall, in its discretion, select and apply in good faith as of the given date.
|
|
(p)
|
“Non-Employee Director” means a Director who, at the time in question, is not an employee of the Company or any of its Affiliates.
|
|
(q)
|
“Plan” means this Amended and Restated 2007 Directors' Stock Award Plan, as the same may be interpreted by the Board and/or be amended from time to time.
|
|
(r)
|
“Plan Year” shall mean each 12-month period beginning on January 1 and ending on December 31.
|
|
(s)
|
“Retirement Date” means the date the Non-Employee Director (i) ceases to be a Director for any reason and (ii) has experienced a “separation from service” as that term is used in Code Section 409A.
|
3.
|
Term
. The Plan originally became effective upon its approval by the Company’s shareholders at the Company’s 2007 Annual Meeting of Shareholders. The amendment and restatement of the Plan provided herein is subject to shareholder approval at the Company’s 2013 Annual Meeting of Shareholders. The Plan shall continue in effect, unless sooner terminated pursuant to Section 9, until the tenth anniversary of the date of the latest shareholder approval of the Plan.
|
4.
|
Stock Subject to Plan
.
|
4.1.
|
Number of Shares
. Subject to the provisions of Section 4.2, the maximum aggregate number of shares of Common Stock that are available for issuance under the Plan is 250,000 shares. The foregoing limitation shall be adjusted proportionately in connection with any Adjustment Event as provided in Section 4.2. The shares may consist, in whole or in part, of Common Stock held in treasury or authorized but unissued shares of Common Stock, not reserved for any other purpose, or reacquired Common Stock. No fractional shares of Common Stock shall be issued hereunder.
|
4.2.
|
Change in Capitalization
. In the event of any Adjustment Event (including, without limitation, any Adjustment Event occurring after the amendment and restatement of the Plan but prior to shareholder approval of the amended and restated Plan), the Board may make such adjustments in (i) the aggregate number of shares of Common Stock that may be issued under the Plan as set forth in Section 4.1 and the number of shares of Common Stock credited in the form of phantom stock in a Non-Employee Director’s Account, and (ii) the class of shares that may be issued under the Plan. The determination by the Board as to the terms of any of the foregoing adjustments shall be final, conclusive and binding for all purposes of the Plan.
|
5.
|
Annual Stock Award Eligibility and Amount
.
|
5.1.
|
Eligibility
. All Non-Employee Directors shall be eligible to participate in the Plan; provided, however, that the Company and Non-Employee Director may agree in writing that such Non-Employee Director shall not participate in the Plan.
|
5.2.
|
Amount
. The Annual Stock Award Amount shall mean the amount of fees a Non-Employee Director will be entitled to receive pursuant to the Plan for serving as a Director in a relevant Plan Year, as determined below.
|
5.3.
|
Pre-2013
. For Plan Years prior to the 2013 Plan Year, the amount of each Non-Employee Director’s Annual Stock Award Amount shall be determined by adding (A) $3,500 for each meeting of the Board attended by such Non-Employee Director during the relevant Plan Year, (B) $500 for each meeting of a committee of the Board attended by such Non-Employee Director during the relevant Plan Year and (C) an additional $500 for each meeting of a committee of the Board at which such Non-Employee Director served as Chairman. A Non-Employee Director may forego the portion of his or her Annual Stock Award Amount that relates to any one or more meeting(s) of the Board or committee thereof by giving irrevocable written notice to such effect to the Secretary of the Company 30 days prior to the date of such meeting.
|
5.4.
|
2013 and Post-2013
. For Plan Years commencing with and following the 2013 Plan Year, each Non-Employee Director’s Annual Stock Award Amount shall be $40,000; provided, that in the event a person serves as a Non-Employee Director for less than a full Plan Year, such amount shall be prorated based on the number of whole calendar months such person served as a Non-Employee Director during such Plan Year. Additionally, for a Non-Employee Director who is a Lead Director during such Plan Year, the Annual Stock Award Amount shall be increased by $5,000; provided, that in the event a Non-Employee Director is a Lead Director for less than a full Plan Year, such amount shall be prorated based on the number of days such person served as a Lead Director for the Plan Year. Notwithstanding the foregoing, a Non-Employee Director must be serving as such on the last day of the Plan Year to be entitled to any Annual Stock Award Amount for such Plan Year.
|
6.
|
Payment of Annual Stock Award Amount
. Unless deferred as provided in Section 7, each Non-Employee Director shall be paid within 30 days of the applicable Credit Date for a Plan Year, the number of shares of Common Stock determined by dividing his or her Annual Stock Award Amount for such Plan Year by the Fair Market Value of the Common Stock on the Credit Date. The number of shares of Common Stock distributed to each Non-Employee Director shall be rounded down to the nearest whole number.
|
7.
|
Deferrals
.
|
7.1.
|
Generally
. Subject to the terms and conditions of the Plan, a Non-Employee Director may elect to defer all of the shares of Common Stock payable under Section 6 for services provided in a Plan Year. Such election shall be made in accordance with this Section 7.
|
7.2.
|
Deferral Election
. All elections to defer shares of Common Stock payable under the Plan shall:
|
|
·
|
be made in writing and delivered to the Company,
|
|
·
|
be irrevocable once the Plan Year to which the election relates commences, and
|
|
·
|
be made before January 1 of the Plan Year in which the Non-Employee Director provided the services that otherwise would have resulted in the payment of the shares of Common Stock under Sections 5 and 6 (or, in the case of an individual who becomes a Non-Employee Director during a Plan Year, and to the extent permitted under Code Section 409A, within 30 days of the date of becoming a Non-Employee Director).
|
7.3.
|
Deferred Account
. On the Credit Date, a Non-Employee Director who has elected to defer shares of Common Stock under the above shall receive a phantom share credit to his or her Account. The amount of such credit shall equal the number of shares so deferred.
|
7.4.
|
Payment of Account
. Except as provided in the immediately following paragraph with respect to a Change in Control, a Non-Employee Director’s Account shall be paid out in shares of Common Stock. Shares of Common Stock deferred pursuant to this Section 7 shall be payable to the Non-Employee Director or, in the event of his or her death, to his or her Beneficiary, within 30 days of the Non-Employee Director’s Retirement Date.
|
7.5.
|
Beneficiary
. A Non-Employee Director may designate any person to whom payments are to be made if the Non-Employee Director dies before receiving payment of all amounts due hereunder (such designated person, a “Beneficiary”). If the Non-employee Director fails to designate a Beneficiary or if the designated Beneficiary predeceases the Non-Employee Director, the Non-Employee Director’s Beneficiary will be deemed to be his or her estate.
|
7.6.
|
Form of Elections
. All elections (including, without limitation, deferral elections, Beneficiary designations) shall be made in the form and manner prescribed by the Board.
|
8.
|
Administration.
|
8.1.
|
Board
. The Plan will be administered by the Board. The Board will act by a majority of its members at the time in office and eligible to vote on any particular matter, and may act either by a vote at a meeting or in writing without a meeting.
|
8.2.
|
Authority
. Except as limited by law and subject to the provisions herein, the Board has full power to: construe and interpret the Plan and any agreement or instrument entered into under the Plan; establish, amend or waive rules and regulations for the Plans administration; and amend the terms and conditions of the Plan. Further, the Board will make all other determinations which may be necessary or advisable for the administration of the Plan. As permitted by law and consistent with Section 8.1, the Board may delegate some or all of its authority under the Plan. The Board shall be entitled to rely conclusively upon all tables, valuations, certificates, opinions and reports furnished by any actuary, accountant, controller, counsel or other person employed or engaged by the Board or Company with respect to the Plan.
|
8.3.
|
Decisions Binding
. All determinations and decisions made by the Board pursuant to the provisions of the Plan will be final, conclusive and binding on all persons, including the Company, its stockholders, all Affiliates of the Company, Non-Employee Directors and their estates and Beneficiaries.
|
9.
|
Amendment and Termination
. The Plan may be amended or terminated at any time by action of the Board; provided, however, that the Company will seek shareholder approval for any change to the extent required by applicable law.
|
10.
|
Miscellaneous
.
|
|
10.1.
|
No Additional Rights
. Nothing contained herein shall be deemed to create a right in any Non-Employee Director to remain a member of the Board, to be nominated for reelection or to be reelected as such. Nothing in the Plan will be construed to limit in any way the right of the Board and/or Company shareholders to remove a Non-Employee Director from the Board.
|
|
10.2.
|
No Stock Rights
. A Non-Employee Director shall not have any rights as a stockholder of the Company with respect to amounts payable under Section 6 of the Plan, or with respect to any phantom shares of Common Stock credited to his or her Account, unless and until shares of Common Stock are issued to him or her in respect thereof. No adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date such certificate or certificates are issued, except as provided in Section 4.
|
|
10.3.
|
Governing Law
. The Plan (including, without limitation, any rules, regulations, determinations or decisions made by the Board or Company relating to the Plan) shall be construed and administered exclusively in accordance with applicable federal laws and the laws of the State of New Jersey, determined without regard to the application of the principles of conflicts of law of New Jersey or of any other jurisdiction.
|
10.4.
|
Indemnification
. Each person who is or has been a member of the Board will be indemnified and held harmless by the Company against and from any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by that person in connection with or resulting from any claim, action, suit, or proceeding to which that person may be a party or in which that person may be involved by reason of any action taken or failure to act under the Plan and against and from any and all amounts paid by that person in a settlement approved by the Company, or paid by that person in satisfaction of any judgment in any such action, suit, or proceeding against that person, provided he or she gives the Company an opportunity, at its own expense, to handle and defend the action, suit or proceeding before that person undertakes to handle and defend it. The foregoing right of indemnification will not be exclusive of any other rights of indemnification to which an individual may be entitled under the Company’s Certificate of Incorporation or By-Laws, as a matter of law, or otherwise, or any power that the Company may have to indemnify him or her or hold him or her harmless.
|
|
10.5.
|
Limitation on Liability
. Notwithstanding any of the preceding provisions of the Plan, neither the Board, any member of the Board, the Company nor any individual acting as an employee or agent of the Company, shall be liable to any Non-Employee Director, Beneficiary, or any other person for any claim, loss, liability or expense incurred in connection with the Plan.
|
|
10.6.
|
Nonassignability
. No right to receive any payments under the Plan or any amounts credited to a Non-Employee Director’s Account may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution, or pursuant to a domestic relations order (as defined in Code Section 414(p)). All rights with respect to an Account will be available during the Non-Employee Director’s lifetime only to the Non-Employee Director or the Non-Employee Director’s guardian or legal representative. The Board may, in its discretion, require a Non-Employee Director’s guardian or legal representative to supply it with evidence the Board deems necessary to establish the authority of the guardian or legal representative to act on behalf of the Non-Employee Director. The designation of a Beneficiary by a Non-Employee Director does not constitute a transfer.
|
|
10.7.
|
Successors
. All obligations of the Company under the Plan will be binding on any successor to the Company, whether the existence of the successor is the result of a direct or indirect purchase of all or substantially all of the business and/or assets of the Company, or a merger, consolidation, or otherwise.
|
|
10.8.
|
Unfunded Plan
. The Plan is intended to constitute an unfunded plan. No Non-Employee Director, Beneficiary, or any other person shall have any interest in any particular assets of the Company by reason of the right to receive a payment under the Plan and any such Non-Employee Director, Beneficiary, or other person shall have only the rights of a general unsecured creditor of the Company with respect to any rights under the Plan.
|
|
10.9.
|
Requirements of Law
. It is the intention of the Company that all transactions under the Plan be exempt from liability imposed by Section 16(b) of the Exchange Act. Therefore, if any transaction under the Plan is found not to be in compliance with an exemption from such Section 16(b), the provision of the Plan governing such transaction shall be deemed amended so that the transaction does so comply and is so exempt, to the extent permitted by law and deemed advisable by the Board, and in all events the Plan shall be construed in favor of its meeting the requirements of an exemption. The issuance of payments under the Plan will be subject to all applicable laws, rules, and regulations, and to any approvals required by any governmental agencies or national securities exchanges. Scheduled Plan payments will be delayed where the Board reasonably anticipates that the making of the payment will violate Federal securities laws or other applicable law; provided that such payment shall be made at the earliest date at which the Board reasonably anticipates that the making of the payment will not cause such violation.
|
10.10.
|
Code Section 409A Compliance
. To the extent any provision of the Plan or action by the Board would subject any Non-Employee Director to liability for interest or additional taxes under Code Section 409A, it will be deemed null and void, to the extent permitted by law and deemed advisable by the Board. It is intended that the Plan will comply with Code Section 409A, and the Plan shall be interpreted and construed on a basis consistent with such intent. The Plan may be amended in any respect deemed necessary (including retroactively) by the Board in order to preserve compliance with Code Section 409A. If, regardless of the foregoing, any Non-Employee Director is liable for interest or additional taxes under Code Section 409A with respect to payments hereunder or his or her Account (or a portion thereof), such payment or Account (or applicable portion thereof) shall be paid at such time. The preceding shall not be construed as a guarantee of any particular tax effect for any benefits or amounts deferred or paid out under the Plan.
|
10.11.
|
Cooperation
. A Non-Employee Director or Beneficiary shall, as a condition of receiving benefits under the Plan, be obligated to provide the Board with such information as the Board shall require in order to administer the Plan.
|
10.12.
|
Gender and Number
. Except where otherwise indicated by the context, any masculine term used herein will also include the feminine; the plural will include the singular and the singular will include the plural.
|
10.13.
|
Severability
. If any provision of the Plan is held illegal or invalid for any reason, the illegality or invalidity will not affect the remaining parts of the Plan, and the Plan will be construed and enforced as if the illegal or invalid provision had not been included.
|
![]()
EMCORE CORPORATION ATTN:
GENERAL COUNSEL
10420 RESEARCH RD SE
ALBUQUERQUE, NM 87123
|
VOTE BY INTERNET - www.proxyvote.com
Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time on Tuesday, March 5, 2013. Haveyour proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.
ELECTRONIC
DELIVERY
OF FUTURE PROXY
MATERIALS
If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions up until 11:59
P.M. Eastern Time on Tuesday, March 5, 2013. Have your proxy card in hand when you call and then follow the instructions.
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
|
EMCORE CORPORATION
10420 Research Road, SE Albuquerque, New Mexico 87123
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned hereby appoints Hong Q. Hou and Mark Weinswig, and each of them, as proxies for the undersigned, each with full power of substitution, for and in the name of the undersigned to act for the undersigned and to vote, as designated on the reverse side of this proxy card, all of the shares of stock of the Company that the undersigned is entitled to vote at the 2013 Annual Meeting of Shareholders of the Company, to be held at 10:00 a.m. local time on Wednesday, March 6, 2013, at The Hyatt Regency Tamaya, 1300 Tuyuna Trail, Santa Ana Pueblo, NM 87004, or at any adjournments or postponements thereof.
THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED SHAREHOLDER. IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED "FOR" THE ELECTION OF THE DIRECTOR NOMINEES LISTED IN PROPOSAL (1), "FOR" THE RATIFICATION OF KPMG LLP AS EMCORE'S INDEPENDENT AUDITORS IN PROPOSAL (2), "FOR" AMENDMENT AND RESTATEMENT OF THE EMCORE CORPORATION 2007 DIRECTORS' STOCK AWARD PLAN IN PROPOSAL (3), "FOR" APPROVING, ON AN ADVISORY BASIS, EXECUTIVE COMPENSATION IN PROPOSAL (4), AND IN THE DISCRETION OF THE PROXIES UPON SUCH OTHER MATTERS AS MAY PROPERLY COME BEFORE THE ANNUAL MEETING.
Continued and to be signed on reverse side
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
No Customers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|